Agilent Technologies, Inc.

Valuation Analysis

About the Company

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custo

Agilent Technologies, Inc. Stock at a Glance

Agilent Technologies, Inc. (A) is currently trading at $129.84 with a market capitalization of $36.7B. The trailing P/E ratio stands at 26.02x, with a forward P/E of 19.65x. The 52-week range spans from $108.35 to $160.27; the current price is 19% below the yearly high. Year-over-year revenue growth stands at +10.0%. The net profit margin stands at 19.55%.

💰 Dividend

Agilent Technologies, Inc. pays an annual dividend of $1.02 per share, representing a yield of 0.79%. The payout ratio stands at 20.2%.

📊 Analyst Rating

17 analysts rate Agilent Technologies, Inc. (A) on consensus: Buy. The average price target is $160.35, implying +23.5% from the current price. Analyst price targets range from $144.00 to $185.00.

Agilent Technologies, Inc.: The Investment Case in Detail

Agilent Technologies, Inc. (A) operates in the Healthcare — specifically Diagnostics & Research — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 10% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 60% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. The combination of a 52.64% gross margin and 23.71% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat.

Valuation in Context

The PEG ratio at 1.28 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

What to Watch Next

• The forward P/E of 19.65x is meaningfully below the trailing 26.02x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 23.5% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

The price is in a transition zone relative to the moving averages — no clear signal.

Risk Profile

The data points to market-like volatility.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Agilent Technologies, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.